Literature DB >> 29582115

Osteonecrosis in sickle cell disease patients from Bahia, Brazil: a cross-sectional study.

Gildasio Daltro1, Bruno Adelmo Franco1, Thiago Batista Faleiro1, Davi Araujo Veiga Rosário1, Paula Braga Daltro2, Vitor Fortuna3.   

Abstract

PURPOSE: The aim of this study was to describe the clinical features of osteonecrosis (ON) in sickle cell disease (SCD) patients in Bahia, a Northeast state with the highest prevalence of the disease in Brazil.
METHODS: Between 2006 and 2017, 283 cases of osteonecrosis in SCD patients were enrolled to analyse the age at diagnosis, genotype, gender, pain, distribution of the lesions and disease staging. MRI and radiograph were obtained at the participation.
RESULTS: Of the 283 SCD cases, 120 (42.4%) were haemoglobin SS genotype while 163 (57.6%) were SC genotype. Two hundred and forty-six cases were bilateral and 37 were unilateral, with an average age at diagnosis of 33.7 (range 10-67) years. The most frequent identified ON site not only was the hip (74.6%), but also affected shoulder, knee and ankle. Most cases presented at early stage I (172, 60.8%) disease. No significant differences on the features of osteonecrosis were identified between haemoglobin SS and haemoglobin SC cases.
CONCLUSIONS: Given the relatively high prevalence of bilateral osteonecrosis at early stages, painful symptoms and rather late age at diagnosis, SCD patients should have radiological examination of their joints more often in order to prevent severe functional disability and increase patient's life quality.

Entities:  

Keywords:  Bone necrosis; Femoral head; Joint; MRI diagnosis; Sickle cell disease

Mesh:

Year:  2018        PMID: 29582115     DOI: 10.1007/s00264-018-3905-z

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  24 in total

1.  Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis.

Authors:  Clinton Baldwin; Vikki G Nolan; Diego F Wyszynski; Qian-Li Ma; Paola Sebastiani; Stephen H Embury; Alice Bisbee; John Farrell; Lindsay Farrer; Martin H Steinberg
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

2.  A proposed treatment algorithm for adults with Haemoglobin SC disease.

Authors:  Veronique Naessens; Richard Ward; Kevin H M Kuo
Journal:  Br J Haematol       Date:  2017-07-12       Impact factor: 6.998

3.  Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.

Authors:  Oyebimpe Adesina; Ann Brunson; Theresa H M Keegan; Ted Wun
Journal:  Blood Adv       Date:  2017-07-11

Review 4.  Bone and joint disease in sickle cell disease.

Authors:  Christine Aguilar; Elliott Vichinsky; Lynne Neumayr
Journal:  Hematol Oncol Clin North Am       Date:  2005-10       Impact factor: 3.722

5.  The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease.

Authors:  Ph Hernigou; A Habibi; D Bachir; F Galacteros
Journal:  J Bone Joint Surg Am       Date:  2006-12       Impact factor: 5.284

6.  A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis.

Authors:  Jean-Philippe Hauzeur; Michel Malaise; Viviane de Maertelaer
Journal:  Int Orthop       Date:  2016-01-05       Impact factor: 3.075

Review 7.  Intravascular hemolysis and the pathophysiology of sickle cell disease.

Authors:  Gregory J Kato; Martin H Steinberg; Mark T Gladwin
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

8.  Sickle cell disease as a cause of osteonecrosis of the femoral head.

Authors:  P F Milner; A P Kraus; J I Sebes; L A Sleeper; K A Dukes; S H Embury; R Bellevue; M Koshy; J W Moohr; J Smith
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease.

Authors:  M Mukisi-Mukaza; A Elbaz; Y Samuel-Leborgne; L Kéclard; C Le Turdu-Chicot; E Christophe-Duchange; G Mérault
Journal:  Orthopedics       Date:  2000-04       Impact factor: 1.390

10.  Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles.

Authors:  Milena Magalhães Aleluia; Teresa Cristina Cardoso Fonseca; Regiana Quinto Souza; Fábia Idalina Neves; Caroline Conceição da Guarda; Rayra Pereira Santiago; Bruna Laís Almeida Cunha; Camylla Villas Boas Figueiredo; Sânzio Silva Santana; Silvana Sousa da Paz; Júnia Raquel Dutra Ferreira; Bruno Antônio Veloso Cerqueira; Marilda de Souza Gonçalves
Journal:  BMC Hematol       Date:  2017-09-15
View more
  6 in total

1.  Hip osteonecrosis: stem cells for life or behead and arthroplasty?

Authors:  Philippe Hernigou; Gildasio Daltro; Jacques Hernigou
Journal:  Int Orthop       Date:  2018-06-08       Impact factor: 3.075

2.  Osteonecrosis of the femoral head: genetic basis.

Authors:  Tracy Wang; Bouziane Azeddine; Wayne Mah; Edward J Harvey; David Rosenblatt; Chantal Séguin
Journal:  Int Orthop       Date:  2018-10-17       Impact factor: 3.075

3.  Polymorphisms and avascular necrosis in patients with sickle cell disease - A systematic review.

Authors:  Márcio Passos Leandro; Natália Damasceno Almeida; Lara Santana Hocevar; Cloud Kennedy Couto de Sá; Amâncio José de Souza; Marcos Almeida Matos
Journal:  Rev Paul Pediatr       Date:  2022-05-11

4.  Stem cell therapy in bilateral osteonecrosis: computer-assisted surgery versus conventional fluoroscopic technique on the contralateral side.

Authors:  Philippe Hernigou; Benjamin Thiebaut; Victor Housset; Claire Bastard; Yasuhiro Homma; Younes Chaib; Charles Henri Flouzat Lachaniette
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

5.  Short-Term Outcome and MRI Changes in Three Adult Patients with Sickle Cell Disease and Aseptic Osteonecrosis after Treatment with Hyperbaric Oxygen Therapy: A Preliminary Report.

Authors:  Amr Shier; Mohamed Abdelrazek; Ashraf Soliman; Vincenzo De Sanctis; Ahmed Elsayed; Mohamed Abdulla; Shehab Mohamed; Khadra Yassin; Ilham Bilal; Mohamed Yassin
Journal:  Case Rep Oncol       Date:  2020-04-02

6.  COMPARISON BETWEEN CONCENTRATED BONE MARROW ASPIRATE AND CORTICOID IN GLUTEAL TENDINOPATHY.

Authors:  Davi Araújo Veiga Rosário; Thiago Batista Faleiro; Bruno Adelmo Ferreira Mendes Franco; Gildásio DE Cerqueira Daltro; Reinaldo Marchetto
Journal:  Acta Ortop Bras       Date:  2021 Jan-Feb       Impact factor: 0.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.